Crusarthrosis (Ankle Osteoarthritis)
Crusarthrosis refers to the damage of the articular cartilage of the ankle joint. As a rule, it involves cartilage destruction and the formation of osteophytes or spurs—abnormal bony overgrowths. With crusarthrosis, pain, redness, and a subcutaneous burning sensation appear after physical exertion on the ankle joint, and swelling may also occur. Mobility becomes restricted. After an extended period of rest, the painful sensations disappear.
The development of crusarthrosis is often preceded by a joint injury or disease. Furthermore, even timely treatment and proper rehabilitation do not guarantee that ankle osteoarthritis will not develop in the future. Unfortunately, this can occur anywhere from a few months to decades later—and ankle joint treatment will be required once again.
Risk Groups
The high-risk group primarily includes runners, track and field athletes, pregnant women, and individuals who are overweight.
Arthro-medullary shunting is a patented Russian technique that has been successfully utilized since 2010 for the treatment of ankle joint pathologies.
The method integrates advanced medical technologies with the utilization of the body's autologous resources.
Indications for Arthro-Medullary Shunting of the Ankle Joint
- Stage I–III crusarthrosis
- Anterior and posterior ankle impingement syndrome
- Avascular necrosis (aseptic necrosis) of the talus
- Chronic pain syndrome (lasting more than 6 months)
- The waiting period for joint arthroplasty (replacement)
- High body mass index (BMI) acting as a contraindication for joint replacement
- Inability or unwillingness to undergo arthroplasty
